Randomized, Placebo-controlled, Dose-escalation, Double-blind Study of Dasiglucagon Effects on QTc in Healthy Volunteers

First published in Current Therapeutic Research in 2022.
Current Therapeutic Research, Volume 96, 2022, Article 100668 doi.org/10.1016/j.curtheres.2022.100668

Authors: Ramin Tehranchi MD, PhD, MBA, Anita E.Melgaard MSc, Friedeborg Seitz MD, Anders Valeur PhD, Stine Just Maarbjerg PhDS

 

 

 

 

Read more

Download full article as Pdf file:

Pdf File

 

REACHING OUT IS EASY AND FAST – LET’S TALK

Prof. Dr. Thomas Forst

Chairman of the Executive Board
located at CRS Mannheim


LET’S TALK SCIENCE
Dr. Marc Hetzel

VP & Head of Business Development
located at CRS Management


LET’S TALK BUSINESS